NASDAQ:OTLK   Outlook Therapeutics, Inc.
Price is at the POC line (1yr) with increasing avg. daily volume since mid April.

OBV is displaying bullish divergence since June as it has been increasing while the price has been decreasing.

RSI is about to cross over its 13 ema.

Targeting: 2.25, 2.66
Stop 2x ATR at $1.56


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.